Word Lists Word Search

List of 10-letter words ending with

Rapid Mode

Click to choose the fifth to last letter

Click to remove the fifth to last letter

Click to change word size
All alphabeticalAll by size58910111213


There are 19 ten-letter words ending with IMAB

abelacimabamatuximabcemiplimabcilgavimabetesevimabinfliximabisatuximableronlimabmaftivimabnirsevimabodesivimabpriliximabrelatlimabsasanlimabsiltuximabsintilimabsotrovimabspesolimabsutimlimab

19 definitions found

  • abelacimab — n. A type of anticoagulant medication.
  • amatuximab — n. (Pharmacology) A chimeric monoclonal antibody designed for…
  • cemiplimab — n. A monoclonal antibody used to treat some skin cancers.
  • cilgavimab — n. A monoclonal antibody used to control coronavirus infection.
  • etesevimab — n. A monoclonal antibody used with bamlanivimab.
  • infliximab — n. (Pharmacology) An immunosuppressive drug (trademark Remicade)…
  • isatuximab — n. A monoclonal antibody medication for the treatment of multiple myeloma.
  • leronlimab — n. A monoclonal antibody proposed as a treatment for COVID-19.
  • maftivimab — n. A monoclonal antibody used in the combination drug atoltivimab/maftivimab/odes…
  • nirsevimab — n. A drug used to treat viral infections of the respiratory tract.
  • odesivimab — n. A monoclonal antibody used in the combination drug atoltivimab/maftivimab/odes…
  • priliximab — n. (Pharmacology) A chimeric monoclonal antibody designed to treat…
  • relatlimab — n. A monoclonal antibody designed for the treatment of melanoma.
  • sasanlimab — n. A particular monoclonal antibody.
  • siltuximab — n. (Pharmacology) A monoclonal antibody and antineoplastic.
  • sintilimab — n. A particular monoclonal antibody.
  • sotrovimab — n. (Medicine) A monoclonal antibody used to treat COVID-19.
  • spesolimab — n. A monoclonal antibody used to treat psoriasis and similar conditions.
  • sutimlimab — n. A monoclonal antibody used to treat adults with cold agglutinin disease.
Previous ListNext List
Random wordBack to top

Recommended websites



Ortograf Inc.This site uses web cookies, click to learn more. Our privacy policy.
© Ortograf Inc. Website updated on 23 June 2023 (v-2.0.1z). Informations & Contacts.